Duo Oncology has filed a notice of an exempt offering of securities to raise $4,175,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Duo Oncology is raising $4,175,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Sam Rothstein played a key…